Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Indopoly Swakarsa Industry Tbk (IPOL) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Indopoly Swakarsa Industry TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Indopoly Swakarsa Industry Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Indopoly Swakarsa Industry Tbk trades at Rp113 (market cap 728.1B, 614.4K 24h volume). The key difference: Indopoly Swakarsa Industry Tbk is far larger — about 2.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Indopoly Swakarsa Industry Tbk is more actively traded (614.4K versus 41.7K). Which is the better fit depends on your goals.

DGNSIPOL
Market Cap
316.25B728.1B
Volume
41.7K614.4K
Lot
4176.14K
Turnover
9.66M69.94M
Average Price
231.65113.84
Value
9.66M69.94M
Indicative Equilibrium Price
230113
Indicative Equilibrium Volume
2.4K376

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
IPOL
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Indopoly Swakarsa Industry Tbk

PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on IPOL